Quantification of a Pharmacodynamic ERK End Point in Melanoma Cell Lysates: Toward Personalized Precision Medicine
MAPKs - ERK1& 2 (Ser/Thr)
Multiple kinases
Inhibitor discovery & SARCell & tissue lysate assaysAssay & sensor technology
Technology origin
